Oramed Pharmaceuticals logo

Oramed Pharmaceuticals

ORMP | NASDAQ
Chart Builder DCF Calculator
$3.90
+$0.19 (+5.12%)
At close: Nov 16, 2026, 4:00 PM ET
$3.89
-$0.01 (-0.26%)
After-hours: Nov 16, 2026, 7:01 PM ET
+5.12%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
31.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #751/1021 (Top 74%)

Key Statistics

Market Data

Market Cap $169.6M
1D Range
3.70 4.05
52W Range
2.34 5.34

Valuation (TTM)

PE 1.14
PB 0.50
EV/EBITDA 1.17

Valuation (NTM)

Forward PE 0.83
Forward PEG -0.00
Price Target $0.00
Loading financial charts...

Profile

Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally inge...

Sector Healthcare
Industry Biotechnology
Employees 13
IPO Date May 1, 2007
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.